1. Swaminathan S, Menon PA, Gopalan N, Perumal V, Santhanakrishnan RK, Ramachandran R, Chinnaiyan P, Iliayas S, Chandrasekaran P, Navaneethapandian PD, Elangovan T, Pho MT, Wares F, Ramalyengar NP. Efficacy of a Six-Month versus a 36-Month Regimen for Prevention of Tuberculosis in HIV-Infected Persons in India: A Randomized Clinical Trial. PLos One, 2012; 7 (12): e47400. doi:10.1371/journal.pone.0047400.
2. World Health Organization. WHO three I’s meeting intensified case finding (ICF): isoniazid preventive therapy (IPT) and TB infection control (IC) for people living with HIV (Geneva: Report of Joint WHO HIV/AIDS and TB Department). 2008; Available from: http://www.who.int/hiv/pub/tb/3is_mreport/en/
3. World Health Organization. Stop TB Department: Global Tuberculosis Control Report. 2011b; Geneva
4. Alemie GA, Gebreselassie F. Common Types of Tuberculosis and Co-Infection with HIV at Private Health Institutions in Ethiopia: A Cross Sectional Study. BMC Public Health. 2014; 14: 319.
5. World Health Organization. Global Tuberculosis Report. 2017; Geneva: Switzerland.
6. Satiavan I, Hartantri Y, Werry B, Nababan Y, Wisaksana R, Alisjahban B. Effect of Isoniazid Preventive Therapy on Tuberculosis Incidence in People Living with HIV – AIDS at HasanSadikin Hospital. ICTRONI, Earth and Environmental Science. 2018; 125:012006. doi :10.1088/1755-1315/125/1/012006
7. Sumner T, Houben RMGJ, Rangaka MX, Maartens G, Boulle A, Wilkinson RJ, White RG. Post-Treatment Effect of Isoniazid Preventive Therapy on Tuberculosis Incidence in HIV-Infected Individuals on Antiretroviral Therapy. AIDS. 2016; 30(8):1279-1286.
8. Churchyard GJ, Mametja LD, Mvusi L, Ndjeka N, Hesseling AC, Reid A, Babatunde S, Pillay Y. Tuberculosis Control in South Africa: Successes, Challenges and Recommendations. South African Medical Journal. 2014:104 (3): 244-248. DOI:10.7196/samj.7689 [2015 November, 15].
9. Samandari T, Agizew TB, Nyirenca S, Tedla Z, Sibanda T, Mosimaneotsile B, Motsamai OI, Shang N, Rose CE, Shepherd J. Tuberculosis Incidence after 36 Months Isoniazid Prophylaxis in HIV-Infected Adults in Botswana: A Post-Trial Observational Analysis. AIDS; 2015: 29:351-359.
10. National Guidelines for Comprehensive HIV Prevention, Care and Treatment, 2014: FDRE, Ministry of Health (MOH), Addis Ababa, Ethiopia.
11. World Health Organization (WHO), Guidelines for Intensified Case-Finding and Isoniazid Preventive Therapy for People Living With HIV in Resource-Constrained Settings. 2011: Geneva, Switzerland:
12. World Health Organization (WHO), Three 'I's Meeting: Intensified Case Finding, Isoniazid Preventive Therapy and TB Infection Control for People Living with HIV, Report of a Joint WHO HIV/AIDS and TB Department Meeting 2-4 April. 2008: Geneva, Switzerland.
13. Sandra Z, Russell K, Edward S, Henry MB, Obsie T, Ighovwerha O, Admasu T. Improving Tuberculosis Screening and Isoniazid Preventative Therapy in an HIV Clinic in Addis Ababa, Ethiopia, Int J Tuberc Lung Dis. 2013;17(11): 1396–1401.doi: 10.5588/ijtld.13.0315.
14. Charalambous S, Grant AD, Innes Cm Hoffmann CJ, Dowdeswell R, Pienaar J, Fielding KL, Churchyard GJ. Association of Isoniazid Preventive Therapy with Lower Early Mortality in individuals on Antiretroviral Therapy in a Workplace Programme. AIDS. 2010; 24(5): S5–13. doi: 10.1097/01.aids.0000391010.02774.6f.
15. Thuy TT, Dien TH, Emily B, Thai HL, Tung TV, Anh HM, Nhung VN, Long TN, Sy ND, Sara W. Implementation and Evaluation of an Isoniazid Preventive Therapy Pilot Program among HIV Infected Patients in Vietnam, 2008-2010. Trans R Soc Trop Med Hyg. 2015; 109(10): 653-659. doi: 10.1093/trstmh/trv074.
16. The TEMPRANO ANRS 12136 Study Group, 2015. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The N Engl j Med (27) 373 – 9.
17. Ethiopian Public Health Institute (EPHI) / Ministry of Health (MOH).National TB/HIV Sentinel Surveillance Annual Report (July 2014 – June 015). EPHI/MOH. Addis Ababa, 2015.
18. Getahun H, Granich R, Sculier D, Gunneberg C, Blanc L, Nunn P, Raviglione M. Implementation of Isoniazid Preventive Therapy for People Living with HIV Worldwide: Barriers and Solutions: 2010; AIDS, 24 (5):S57–S65
19. Wesen A, Mitike G. Provision and Awareness for Isoniazid Preventive Therapy among PLHIV in Addis Ababa, Ethiopia. BMC. Int Health Hum Rights. 2012;12(2): http://www.biomedcentral.com/1472-698x/12/2
20. Denegetu AW, Dolamo BL. Tuberculosis Case Finding and Isoniazid Preventive Therapy among People Living With HIV at Public Health Facilities of Addis Ababa, Ethiopia: A Cross-Sectional Facility Based Study. BMC Public Health. 2014;14(52): http://www.biomedcentral.com/1471-2458/14/52
21. Teklay G, Teklu T, Legesse B, Tedla K, Klinkenberg E. Barriers in the Implementation of Isoniazid Preventive Therapy for People Living with HIV in Northern Ethiopia: A Mixed Quantitative and Qualitative Study. BMC Public Health. 2016; 16 (840): DOI 10.1186/s12889-016-3525-8
22. Golub JE, Saraceni V, Cavalcante SC, Pacheco AG, Moulton LH, King BS. The Impact of Antiretroviral Therapy and Isoniazid Preventive Therapy on Tuberculosis Incidence in HIV-Infected Patients in Rio De Janeiro, Brazil. AIDS. 2007; 21:1441–1448.
23. Abossie A, Yohanes T Assessment of Isoniazid Preventive Therapy in the Reduction of Tuberculosis among ART Patients in Arba Minch Hospital, Ethiopia. Therapeutics and Clinical Risk Management. 2017; 13: 361 – 366.
24. Berhe M, Demissie M, Tesfaye G. Isoniazid Preventive Therapy Adherence and Associated Factors among HIV Positive Patients in Addis Ababa, Ethiopia: Advances in Epidemiology. 2014 :http://dx.doi.org/10.1155/2014/230587
25. Munseri PJ, Talbot EA, Mtei L., Fordham CVR. Completion of Isoniazid Preventive Therapy among HIV-Infected Patients in Tanzania. Int J Tuberc Lung Dis. 2008; 12(9):1037–1041.
26. Saiyud M, Saranath L , Petchawan P , Natpatou S, Norio Y, Jaranit K. Barriers to and Motivations for the Implementation of a Treatment Programme for Latent Tuberculosis Infection using Isoniazid for People Living with HIV in Upper Northern Thailand. Global Journal of Health Science.2013; 5(4): 60 – 70. Doi: 10.5539/gjhs.v5n4p60
27. Lester R, Hamilton R, Charalambous S, Dwadwa T, Chandler C, Churchyard G, Grant A. Barriers to Implementation of Isoniazid Preventive Therapy in HIV Clinics: A Qualitative Study. AIDS. 2010; 24: S45-S48.
28. Andrea A, Wafaa M, Sadr E. Integration of Tuberculosis and HIV Services in Sub- Saharan Africa: Lessons Learned in Center for AIDS Care and Treatment Programs. Clin Infect Dis 2010; 50 (S3):S238–44
29. Sisay S., Mekonen A., Abera A., Berhan Y., Kebede T., Ferede A. An Evaluation of Collaboration in the TB and HIV Control Programme in Oromia Region, Ethiopia: Seven Years of Retrospective Data. Int J of Infectious Diseases. 2018: 77: 74–81.